Beatrice Bacchi, Francesco Cabrucci, Bruno Chiarello, Aleksander Dokollari, Massimo Bonacchi
{"title":"Impact of Pleural Integrity Preservation After Minimally Invasive Aortic Valve Surgery.","authors":"Beatrice Bacchi, Francesco Cabrucci, Bruno Chiarello, Aleksander Dokollari, Massimo Bonacchi","doi":"10.1177/15569845241237241","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>While the benefits of minimally invasive aortic valve surgery compared with standard sternotomy have been widely described, the impact of preservation of pleural integrity (PPI) in minimally invasive surgery is still widely discussed. This study aims to define the role of PPI on postoperative and long-term outcomes after minimally invasive aortic valve replacement (MIAVR).</p><p><strong>Methods: </strong>All 2,430 consecutive patients undergoing MIAVR (ministernotomy or right anterior minithoracotomy) between 1997 and 2022 were included in the study. Patients were divided into 2 groups: patients with and without PPI. PPI was considered the maintenance of the pleura closed without the need for a chest tube insertion at the end of the surgical procedure. A propensity-matched analysis was used to compare the PPI and not-PPI groups.</p><p><strong>Results: </strong>After propensity matching, 848 patients were included in each group (PPI and not-PPI). The mean age was 70.21 versus 71.42 years, and the mean Society of Thoracic Surgeons predicted risk of mortality was 0.31% versus 0.30% in not-PPI versus PPI, respectively. The mean follow-up time was 147.4 months. Postoperatively, not-PPI versus PPI patients had a longer intensive care unit stay (9.7 vs 17.3 h, <i>P</i> < 0.001) and hospital length of stay (5.2 vs 8.9 days, <i>P</i> < 0.001). The rate of respiratory complications including the incidence of pneumothorax or subcutaneous emphysema, pulmonary atelectasis, and pleural effusion events requiring thoracentesis/drainage was significantly higher in not-PPI versus PPI. The 30-day all-cause mortality was higher in not-PPI versus PPI (0.029 vs 0.010, <i>P</i> = 0.003). Perioperative, short-term, and long-term all-cause mortality was significantly higher in the not-PPI group.</p><p><strong>Conclusions: </strong>PPI after MIAVR is associated with reduced incidence of postoperative complications, reduced lengths of stay, and improved overall survival compared with not-PPI. Therefore, a MIAVR tailored patient-procedure approach to maintaining the pleura integrity positively impacts short-term and long-term outcomes.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15569845241237241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: While the benefits of minimally invasive aortic valve surgery compared with standard sternotomy have been widely described, the impact of preservation of pleural integrity (PPI) in minimally invasive surgery is still widely discussed. This study aims to define the role of PPI on postoperative and long-term outcomes after minimally invasive aortic valve replacement (MIAVR).
Methods: All 2,430 consecutive patients undergoing MIAVR (ministernotomy or right anterior minithoracotomy) between 1997 and 2022 were included in the study. Patients were divided into 2 groups: patients with and without PPI. PPI was considered the maintenance of the pleura closed without the need for a chest tube insertion at the end of the surgical procedure. A propensity-matched analysis was used to compare the PPI and not-PPI groups.
Results: After propensity matching, 848 patients were included in each group (PPI and not-PPI). The mean age was 70.21 versus 71.42 years, and the mean Society of Thoracic Surgeons predicted risk of mortality was 0.31% versus 0.30% in not-PPI versus PPI, respectively. The mean follow-up time was 147.4 months. Postoperatively, not-PPI versus PPI patients had a longer intensive care unit stay (9.7 vs 17.3 h, P < 0.001) and hospital length of stay (5.2 vs 8.9 days, P < 0.001). The rate of respiratory complications including the incidence of pneumothorax or subcutaneous emphysema, pulmonary atelectasis, and pleural effusion events requiring thoracentesis/drainage was significantly higher in not-PPI versus PPI. The 30-day all-cause mortality was higher in not-PPI versus PPI (0.029 vs 0.010, P = 0.003). Perioperative, short-term, and long-term all-cause mortality was significantly higher in the not-PPI group.
Conclusions: PPI after MIAVR is associated with reduced incidence of postoperative complications, reduced lengths of stay, and improved overall survival compared with not-PPI. Therefore, a MIAVR tailored patient-procedure approach to maintaining the pleura integrity positively impacts short-term and long-term outcomes.
目的:与标准胸骨切开术相比,微创主动脉瓣手术的优势已被广泛描述,但在微创手术中保留胸膜完整性(PPI)的影响仍被广泛讨论。本研究旨在明确 PPI 对微创主动脉瓣置换术(MIAVR)术后和长期预后的作用:研究纳入了 1997 年至 2022 年间接受微创主动脉瓣置换术(小切口或右前小切口)的所有 2430 名连续患者。患者被分为两组:使用和未使用 PPI 的患者。PPI 被认为是在手术结束时无需插入胸管即可保持胸膜闭合。采用倾向匹配分析来比较PPI组和非PPI组:经过倾向匹配后,每组(PPI 组和非 PPI 组)均纳入了 848 名患者。两组患者的平均年龄分别为 70.21 岁和 71.42 岁,胸外科医师协会预测的平均死亡风险分别为 0.31% 和 0.30%。平均随访时间为 147.4 个月。术后,非 PPI 与 PPI 患者在重症监护室的住院时间(9.7 小时 vs 17.3 小时,P < 0.001)和住院时间(5.2 天 vs 8.9 天,P < 0.001)更长。非 PPI 与 PPI 相比,呼吸系统并发症(包括气胸或皮下气肿、肺不张和胸腔积液)的发生率明显更高。非 PPI 与 PPI 相比,30 天全因死亡率更高(0.029 vs 0.010,P = 0.003)。非 PPI 组的围手术期、短期和长期全因死亡率均显著高于 PPI 组:结论:与不使用 PPI 相比,MIAVR 术后使用 PPI 可降低术后并发症的发生率、缩短住院时间并提高总生存率。因此,为患者量身定制的 MIAVR 手术方法可保持胸膜完整性,对短期和长期预后均有积极影响。
期刊介绍:
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery is the first journal whose main mission is to disseminate information specifically about advances in technology and techniques that lead to less invasive treatment of cardiothoracic and vascular disease. It delivers cutting edge original research, reviews, essays, case reports, and editorials from the pioneers and experts in the field of minimally invasive cardiothoracic and vascular disease, including biomedical engineers. Also included are papers presented at the annual ISMICS meeting. Official Journal of the International Society for Minimally Invasive Cardiothoracic Surgery